

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 9.18287303 |
| 2 | interferon-gamma secretion (GO:0072643) | 8.23528543 |
| 3 | magnesium ion transport (GO:0015693) | 7.35120464 |
| 4 | nephron tubule formation (GO:0072079) | 7.14137072 |
| 5 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 7.08857919 |
| 6 | dopamine biosynthetic process (GO:0042416) | 6.88730560 |
| 7 | cGMP-mediated signaling (GO:0019934) | 6.71981633 |
| 8 | valine metabolic process (GO:0006573) | 6.45999801 |
| 9 | dopamine transport (GO:0015872) | 6.35546831 |
| 10 | inner ear receptor cell development (GO:0060119) | 6.31047874 |
| 11 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 6.30209339 |
| 12 | kinetochore assembly (GO:0051382) | 6.04296470 |
| 13 | negative regulation of metanephros development (GO:0072217) | 5.96838741 |
| 14 | neuron cell-cell adhesion (GO:0007158) | 5.72720165 |
| 15 | synaptic vesicle exocytosis (GO:0016079) | 5.65067286 |
| 16 | ear development (GO:0043583) | 5.49619322 |
| 17 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.46643547 |
| 18 | negative regulation of protein autophosphorylation (GO:0031953) | 5.34264651 |
| 19 | vocalization behavior (GO:0071625) | 5.32290713 |
| 20 | glutamate secretion (GO:0014047) | 5.17452647 |
| 21 | mating behavior (GO:0007617) | 5.14393876 |
| 22 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 5.12030628 |
| 23 | catecholamine transport (GO:0051937) | 5.11651541 |
| 24 | alkaloid metabolic process (GO:0009820) | 5.06343683 |
| 25 | pattern specification involved in kidney development (GO:0061004) | 5.01646536 |
| 26 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 4.96293854 |
| 27 | kinetochore organization (GO:0051383) | 4.95931551 |
| 28 | parturition (GO:0007567) | 4.95880147 |
| 29 | prepulse inhibition (GO:0060134) | 4.94094377 |
| 30 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.91112616 |
| 31 | regulation of stem cell maintenance (GO:2000036) | 4.87146196 |
| 32 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 4.85393664 |
| 33 | locomotory exploration behavior (GO:0035641) | 4.84569410 |
| 34 | synaptic transmission, dopaminergic (GO:0001963) | 4.77089994 |
| 35 | DNA strand renaturation (GO:0000733) | 4.76438842 |
| 36 | regulation of dopamine metabolic process (GO:0042053) | 4.75077779 |
| 37 | regulation of catecholamine metabolic process (GO:0042069) | 4.75077779 |
| 38 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 4.73540039 |
| 39 | synaptic vesicle maturation (GO:0016188) | 4.71655347 |
| 40 | neurotransmitter secretion (GO:0007269) | 4.71294285 |
| 41 | positive regulation of action potential (GO:0045760) | 4.65935344 |
| 42 | neurotransmitter biosynthetic process (GO:0042136) | 4.61769987 |
| 43 | response to insecticide (GO:0017085) | 4.42186960 |
| 44 | lens fiber cell development (GO:0070307) | 4.40325606 |
| 45 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.38083766 |
| 46 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.36547396 |
| 47 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 4.36075187 |
| 48 | negative regulation of viral release from host cell (GO:1902187) | 4.29802802 |
| 49 | regulation of neurotransmitter levels (GO:0001505) | 4.26712756 |
| 50 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.23955609 |
| 51 | neurotransmitter transport (GO:0006836) | 4.23723855 |
| 52 | one-carbon compound transport (GO:0019755) | 4.23328002 |
| 53 | mesenchymal to epithelial transition (GO:0060231) | 4.21501421 |
| 54 | mesonephros development (GO:0001823) | 4.17659052 |
| 55 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.17311835 |
| 56 | gamma-aminobutyric acid transport (GO:0015812) | 4.14953376 |
| 57 | neuronal action potential propagation (GO:0019227) | 4.14459701 |
| 58 | behavioral response to cocaine (GO:0048148) | 4.14361777 |
| 59 | positive regulation of hormone metabolic process (GO:0032352) | 4.13462754 |
| 60 | exploration behavior (GO:0035640) | 4.07984571 |
| 61 | cardiovascular system development (GO:0072358) | 4.07664806 |
| 62 | negative regulation of T cell differentiation in thymus (GO:0033085) | 4.07112882 |
| 63 | neuron-neuron synaptic transmission (GO:0007270) | 4.06973711 |
| 64 | negative regulation of kidney development (GO:0090185) | 4.04946275 |
| 65 | negative regulation of interleukin-1 production (GO:0032692) | 4.03431312 |
| 66 | catecholamine biosynthetic process (GO:0042423) | 4.00758758 |
| 67 | catechol-containing compound biosynthetic process (GO:0009713) | 4.00758758 |
| 68 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.99450714 |
| 69 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.93790393 |
| 70 | urogenital system development (GO:0001655) | 3.93709261 |
| 71 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.93146362 |
| 72 | neurotransmitter metabolic process (GO:0042133) | 3.92271464 |
| 73 | neurotransmitter catabolic process (GO:0042135) | 3.89020197 |
| 74 | regulation of synaptic vesicle transport (GO:1902803) | 3.88897591 |
| 75 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.81346823 |
| 76 | protein localization to synapse (GO:0035418) | 3.75098370 |
| 77 | proline transport (GO:0015824) | 3.74946870 |
| 78 | embryonic epithelial tube formation (GO:0001838) | 3.73024090 |
| 79 | response to histamine (GO:0034776) | 3.72703725 |
| 80 | response to cocaine (GO:0042220) | 3.70753916 |
| 81 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.70671956 |
| 82 | regulation of synapse structural plasticity (GO:0051823) | 3.69804302 |
| 83 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.69804267 |
| 84 | negative regulation of neurotransmitter transport (GO:0051589) | 3.69238458 |
| 85 | motile cilium assembly (GO:0044458) | 3.68002808 |
| 86 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 3.67917150 |
| 87 | epithelial tube formation (GO:0072175) | 3.66424071 |
| 88 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.66036567 |
| 89 | neuromuscular process controlling posture (GO:0050884) | 3.65089378 |
| 90 | cysteine metabolic process (GO:0006534) | 3.62211204 |
| 91 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 3.55415879 |
| 92 | neuron recognition (GO:0008038) | 3.54282577 |
| 93 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.54118877 |
| 94 | transmission of nerve impulse (GO:0019226) | 3.53554833 |
| 95 | striatum development (GO:0021756) | 3.53182348 |
| 96 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 3.48786161 |
| 97 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.48672461 |
| 98 | layer formation in cerebral cortex (GO:0021819) | 3.46777187 |
| 99 | regulation of dopamine secretion (GO:0014059) | 3.46725807 |
| 100 | regulation of vesicle fusion (GO:0031338) | 3.46377031 |
| 101 | glutamate receptor signaling pathway (GO:0007215) | 3.45773390 |
| 102 | phenol-containing compound catabolic process (GO:0019336) | 3.45674397 |
| 103 | synaptic transmission, glutamatergic (GO:0035249) | 3.44089880 |
| 104 | nitric oxide mediated signal transduction (GO:0007263) | 3.42922038 |
| 105 | cellular response to interferon-beta (GO:0035458) | 3.42308363 |
| 106 | social behavior (GO:0035176) | 3.41572764 |
| 107 | intraspecies interaction between organisms (GO:0051703) | 3.41572764 |
| 108 | synaptic vesicle transport (GO:0048489) | 3.41399631 |
| 109 | establishment of synaptic vesicle localization (GO:0097480) | 3.41399631 |
| 110 | dopamine metabolic process (GO:0042417) | 3.40584138 |
| 111 | neutrophil activation involved in immune response (GO:0002283) | 3.39536738 |
| 112 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.39480780 |
| 113 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.39361548 |
| 114 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.39361548 |
| 115 | negative regulation of ERK1 and ERK2 cascade (GO:0070373) | 3.39156008 |
| 116 | RNA localization (GO:0006403) | 3.38850210 |
| 117 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.36688917 |
| 118 | CENP-A containing nucleosome assembly (GO:0034080) | 3.36443262 |
| 119 | long-term memory (GO:0007616) | 3.35416918 |
| 120 | cellular potassium ion homeostasis (GO:0030007) | 3.33221303 |
| 121 | auditory behavior (GO:0031223) | 3.32913768 |
| 122 | synaptic vesicle endocytosis (GO:0048488) | 3.32289952 |
| 123 | regulation of protein kinase A signaling (GO:0010738) | 3.31405134 |
| 124 | chromatin remodeling at centromere (GO:0031055) | 3.31162078 |
| 125 | negative regulation of multicellular organism growth (GO:0040015) | 3.29616740 |
| 126 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.29547199 |
| 127 | membrane hyperpolarization (GO:0060081) | 3.29526203 |
| 128 | transepithelial transport (GO:0070633) | 3.27565481 |
| 129 | response to protozoan (GO:0001562) | 3.24848497 |
| 130 | excretion (GO:0007588) | 3.23593923 |
| 131 | positive regulation of synapse assembly (GO:0051965) | 3.23213115 |
| 132 | regulation of postsynaptic membrane potential (GO:0060078) | 3.22537489 |
| 133 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.22313387 |
| 134 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.20606417 |
| 135 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.20463568 |
| 136 | metanephric tubule development (GO:0072170) | 3.18880736 |
| 137 | metanephric nephron tubule development (GO:0072234) | 3.18880736 |
| 138 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 3.18760123 |
| 139 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.18528450 |
| 140 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.18107846 |
| 141 | negative regulation of microtubule polymerization (GO:0031115) | 3.16760905 |
| 142 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 3.16320924 |
| 143 | cerebellar Purkinje cell layer development (GO:0021680) | 3.14518936 |
| 144 | positive regulation of neurotransmitter transport (GO:0051590) | 3.14494581 |
| 145 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.13091266 |
| 146 | synapse assembly (GO:0007416) | 3.12211081 |
| 147 | response to amphetamine (GO:0001975) | 3.11004725 |
| 148 | regulation of glutamate secretion (GO:0014048) | 3.10925450 |
| 149 | positive regulation of vesicle fusion (GO:0031340) | 3.08144621 |
| 150 | cornea development in camera-type eye (GO:0061303) | 3.07926726 |
| 151 | monoamine transport (GO:0015844) | 3.07811054 |
| 152 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.07057435 |
| 153 | iron coordination entity transport (GO:1901678) | 3.06952722 |
| 154 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.06676722 |
| 155 | long-term synaptic potentiation (GO:0060291) | 3.06491254 |
| 156 | serine family amino acid biosynthetic process (GO:0009070) | 3.06488381 |
| 157 | adult walking behavior (GO:0007628) | 3.04748879 |
| 158 | regulation of viral release from host cell (GO:1902186) | 3.04748572 |
| 159 | activation of protein kinase A activity (GO:0034199) | 3.04553180 |
| 160 | opioid receptor signaling pathway (GO:0038003) | 3.02964432 |
| 161 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.02122808 |
| 162 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.02122808 |
| 163 | neurotransmitter uptake (GO:0001504) | 3.01807152 |
| 164 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.01149367 |
| 165 | regulation of neurotransmitter transport (GO:0051588) | 3.01004958 |
| 166 | response to auditory stimulus (GO:0010996) | 3.00827434 |
| 167 | dendritic spine morphogenesis (GO:0060997) | 3.00645463 |
| 168 | barbed-end actin filament capping (GO:0051016) | 2.99948631 |
| 169 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.99640725 |
| 170 | specification of organ identity (GO:0010092) | 2.98190538 |
| 171 | response to peptidoglycan (GO:0032494) | 2.95149793 |
| 172 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.92644810 |
| 173 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.91327986 |
| 174 | atrial cardiac muscle cell action potential (GO:0086014) | 2.90446554 |
| 175 | positive regulation of protein targeting to membrane (GO:0090314) | 2.88246681 |
| 176 | embryonic skeletal system development (GO:0048706) | 2.84234872 |
| 177 | viral protein processing (GO:0019082) | 2.83690469 |
| 178 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.81798941 |
| 179 | metanephric nephron epithelium development (GO:0072243) | 2.80853995 |
| 180 | negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059) | 2.80489496 |
| 181 | cytokine secretion (GO:0050663) | 2.79221386 |
| 182 | leukocyte degranulation (GO:0043299) | 2.76092010 |
| 183 | modulation by virus of host process (GO:0019054) | 2.75405348 |
| 184 | folic acid transport (GO:0015884) | 2.74814812 |
| 185 | negative regulation of macrophage differentiation (GO:0045650) | 2.74355779 |
| 186 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.73547004 |
| 187 | negative regulation of ERBB signaling pathway (GO:1901185) | 2.72052011 |
| 188 | membrane repolarization during action potential (GO:0086011) | 2.72011613 |
| 189 | regulation of mitochondrial fission (GO:0090140) | 2.71710615 |
| 190 | nucleobase catabolic process (GO:0046113) | 2.70035884 |
| 191 | response to interferon-beta (GO:0035456) | 2.69597265 |
| 192 | muscle organ morphogenesis (GO:0048644) | 2.64781740 |
| 193 | negative regulation of viral entry into host cell (GO:0046597) | 2.63989901 |
| 194 | embryonic heart tube development (GO:0035050) | 2.63841715 |
| 195 | granulocyte activation (GO:0036230) | 2.63694115 |
| 196 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.63413608 |
| 197 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.62564358 |
| 198 | ncRNA 3-end processing (GO:0043628) | 2.61092071 |
| 199 | positive regulation of gluconeogenesis (GO:0045722) | 2.60250875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.27091809 |
| 2 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 4.65695451 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.51879301 |
| 4 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 4.33292543 |
| 5 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 4.33292543 |
| 6 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 4.33292543 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.69734170 |
| 8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.19256564 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.18849557 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.04575437 |
| 11 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.90471555 |
| 12 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.89696689 |
| 13 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.75854851 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.65913464 |
| 15 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.60057776 |
| 16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.59144793 |
| 17 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.55112130 |
| 18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.55112130 |
| 19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.52016914 |
| 20 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.48388874 |
| 21 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.48364642 |
| 22 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.46216957 |
| 23 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.45908106 |
| 24 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.45592762 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.40844769 |
| 26 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.39210486 |
| 27 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.35636735 |
| 28 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.27008780 |
| 29 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.23161488 |
| 30 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.21631761 |
| 31 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.19043668 |
| 32 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.18428705 |
| 33 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.18414106 |
| 34 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.16800015 |
| 35 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.11923963 |
| 36 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.11818028 |
| 37 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.11062202 |
| 38 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.08875130 |
| 39 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 12.3918006 |
| 40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.99006448 |
| 41 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.94082654 |
| 42 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.92769395 |
| 43 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.89947164 |
| 44 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.87830827 |
| 45 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.82372086 |
| 46 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.80410373 |
| 47 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.76348887 |
| 48 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.75769512 |
| 49 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.73804420 |
| 50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.72943481 |
| 51 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.61984441 |
| 52 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.61800362 |
| 53 | P300_19829295_ChIP-Seq_ESCs_Human | 1.60084771 |
| 54 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.59586151 |
| 55 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.57617818 |
| 56 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.55154455 |
| 57 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.54411654 |
| 58 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.51655118 |
| 59 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.49157690 |
| 60 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.47767269 |
| 61 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.46478462 |
| 62 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.45864285 |
| 63 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.43049998 |
| 64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42066858 |
| 65 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.39230711 |
| 66 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.38805403 |
| 67 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.38313720 |
| 68 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.38245624 |
| 69 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.37287664 |
| 70 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.37015500 |
| 71 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.35978631 |
| 72 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.35408900 |
| 73 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.35125674 |
| 74 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.34973892 |
| 75 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.34558854 |
| 76 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.34081903 |
| 77 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.31827434 |
| 78 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31704604 |
| 79 | * ERA_21632823_ChIP-Seq_H3396_Human | 1.30708758 |
| 80 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.29943393 |
| 81 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27082918 |
| 82 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26994365 |
| 83 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24126273 |
| 84 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.23097448 |
| 85 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.22979002 |
| 86 | STAT3_23295773_ChIP-Seq_U87_Human | 1.22296502 |
| 87 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.21615560 |
| 88 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.20743861 |
| 89 | FUS_26573619_Chip-Seq_HEK293_Human | 1.19427271 |
| 90 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.18790193 |
| 91 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.18568054 |
| 92 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18050711 |
| 93 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16698751 |
| 94 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.16153513 |
| 95 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.16104996 |
| 96 | VDR_22108803_ChIP-Seq_LS180_Human | 1.15641839 |
| 97 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13981643 |
| 98 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.11707220 |
| 99 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.11564096 |
| 100 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.11360518 |
| 101 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.10597717 |
| 102 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.09660932 |
| 103 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.08906729 |
| 104 | TP53_16413492_ChIP-PET_HCT116_Human | 1.08299112 |
| 105 | AR_19668381_ChIP-Seq_PC3_Human | 1.07986682 |
| 106 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07467478 |
| 107 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.06482913 |
| 108 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.06057044 |
| 109 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.06038433 |
| 110 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05910372 |
| 111 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04023581 |
| 112 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.02971480 |
| 113 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.02570799 |
| 114 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.02432016 |
| 115 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02326454 |
| 116 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.02278315 |
| 117 | BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 1.01327546 |
| 118 | JUN_21703547_ChIP-Seq_K562_Human | 1.01312432 |
| 119 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.99851907 |
| 120 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.98435369 |
| 121 | ATF3_27146783_Chip-Seq_COLON_Human | 0.97347338 |
| 122 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97333296 |
| 123 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.95225798 |
| 124 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.94602966 |
| 125 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.94327300 |
| 126 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.94048091 |
| 127 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.93187442 |
| 128 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.92532926 |
| 129 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92513175 |
| 130 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.92414294 |
| 131 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.91197118 |
| 132 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.90848508 |
| 133 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90063490 |
| 134 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.88906953 |
| 135 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.88777041 |
| 136 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.88352080 |
| 137 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88001676 |
| 138 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.87724162 |
| 139 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.87656328 |
| 140 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.87184229 |
| 141 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.87028707 |
| 142 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.86981519 |
| 143 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86590194 |
| 144 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.86064521 |
| 145 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.85907089 |
| 146 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.84612995 |
| 147 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.84109476 |
| 148 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.84043730 |
| 149 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.84043730 |
| 150 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.83810459 |
| 151 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83721839 |
| 152 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.83432551 |
| 153 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.83430872 |
| 154 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.82494031 |
| 155 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82494031 |
| 156 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.81751962 |
| 157 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.81473992 |
| 158 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.81199653 |
| 159 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.80961904 |
| 160 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.75606829 |
| 161 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.74838176 |
| 162 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.74499261 |
| 163 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.73964568 |
| 164 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.73912218 |
| 165 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.73273036 |
| 166 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.72976937 |
| 167 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.72854533 |
| 168 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.72699306 |
| 169 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.72608783 |
| 170 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.71245054 |
| 171 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.70398530 |
| 172 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.70214957 |
| 173 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.69934784 |
| 174 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.69662507 |
| 175 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.69009371 |
| 176 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.68603404 |
| 177 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.68301185 |
| 178 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.66614744 |
| 179 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.66587471 |
| 180 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.65632900 |
| 181 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.64827321 |
| 182 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.63822651 |
| 183 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.62532384 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006292_abnormal_olfactory_placode | 6.27857336 |
| 2 | MP0003880_abnormal_central_pattern | 5.32407497 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 5.06358277 |
| 4 | MP0002138_abnormal_hepatobiliary_system | 4.73054511 |
| 5 | MP0002254_reproductive_system_inflammat | 4.21175130 |
| 6 | MP0002277_abnormal_respiratory_mucosa | 4.04225996 |
| 7 | MP0003635_abnormal_synaptic_transmissio | 3.87488626 |
| 8 | MP0009046_muscle_twitch | 3.65907349 |
| 9 | MP0005076_abnormal_cell_differentiation | 3.53526538 |
| 10 | MP0001881_abnormal_mammary_gland | 3.46398593 |
| 11 | MP0009745_abnormal_behavioral_response | 3.29679131 |
| 12 | MP0001905_abnormal_dopamine_level | 3.28633762 |
| 13 | MP0002064_seizures | 3.23822130 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 3.23222825 |
| 15 | MP0000372_irregular_coat_pigmentation | 3.18494599 |
| 16 | MP0006276_abnormal_autonomic_nervous | 3.09769098 |
| 17 | MP0004510_myositis | 3.00890728 |
| 18 | MP0001529_abnormal_vocalization | 2.98756989 |
| 19 | MP0002063_abnormal_learning/memory/cond | 2.95873100 |
| 20 | MP0003938_abnormal_ear_development | 2.88489969 |
| 21 | MP0002822_catalepsy | 2.85589582 |
| 22 | MP0005423_abnormal_somatic_nervous | 2.84180036 |
| 23 | MP0001968_abnormal_touch/_nociception | 2.76523566 |
| 24 | MP0002572_abnormal_emotion/affect_behav | 2.74585837 |
| 25 | MP0001501_abnormal_sleep_pattern | 2.68627509 |
| 26 | MP0003122_maternal_imprinting | 2.65456836 |
| 27 | MP0001486_abnormal_startle_reflex | 2.56980049 |
| 28 | MP0002272_abnormal_nervous_system | 2.56168899 |
| 29 | MP0003941_abnormal_skin_development | 2.49381001 |
| 30 | MP0000685_abnormal_immune_system | 2.47871372 |
| 31 | MP0004270_analgesia | 2.45103202 |
| 32 | MP0003183_abnormal_peptide_metabolism | 2.37298035 |
| 33 | MP0010030_abnormal_orbit_morphology | 2.35191267 |
| 34 | MP0001440_abnormal_grooming_behavior | 2.32396238 |
| 35 | MP0002736_abnormal_nociception_after | 2.30476042 |
| 36 | MP0008004_abnormal_stomach_pH | 2.26904370 |
| 37 | MP0002160_abnormal_reproductive_system | 2.24422119 |
| 38 | MP0002102_abnormal_ear_morphology | 2.21386536 |
| 39 | MP0005386_behavior/neurological_phenoty | 2.21378518 |
| 40 | MP0004924_abnormal_behavior | 2.21378518 |
| 41 | MP0002734_abnormal_mechanical_nocicepti | 2.20366955 |
| 42 | MP0002067_abnormal_sensory_capabilities | 2.07322933 |
| 43 | MP0002733_abnormal_thermal_nociception | 2.02920078 |
| 44 | MP0003936_abnormal_reproductive_system | 2.00389033 |
| 45 | MP0003195_calcinosis | 1.99328677 |
| 46 | MP0002909_abnormal_adrenal_gland | 1.92506018 |
| 47 | MP0002557_abnormal_social/conspecific_i | 1.91431878 |
| 48 | MP0001970_abnormal_pain_threshold | 1.89915902 |
| 49 | MP0002396_abnormal_hematopoietic_system | 1.89832998 |
| 50 | MP0003303_peritoneal_inflammation | 1.86838909 |
| 51 | MP0004142_abnormal_muscle_tone | 1.82474539 |
| 52 | MP0002184_abnormal_innervation | 1.79360373 |
| 53 | MP0002249_abnormal_larynx_morphology | 1.73736614 |
| 54 | MP0002735_abnormal_chemical_nociception | 1.73219309 |
| 55 | MP0008872_abnormal_physiological_respon | 1.69251845 |
| 56 | MP0005646_abnormal_pituitary_gland | 1.68897562 |
| 57 | MP0000627_abnormal_mammary_gland | 1.67872030 |
| 58 | MP0003011_delayed_dark_adaptation | 1.66443689 |
| 59 | MP0001984_abnormal_olfaction | 1.60152287 |
| 60 | MP0001188_hyperpigmentation | 1.57664626 |
| 61 | MP0005645_abnormal_hypothalamus_physiol | 1.56156346 |
| 62 | MP0001293_anophthalmia | 1.52912358 |
| 63 | MP0003329_amyloid_beta_deposits | 1.51339425 |
| 64 | MP0008569_lethality_at_weaning | 1.50072641 |
| 65 | MP0009278_abnormal_bone_marrow | 1.48594200 |
| 66 | MP0002098_abnormal_vibrissa_morphology | 1.48109780 |
| 67 | MP0004811_abnormal_neuron_physiology | 1.47033772 |
| 68 | MP0002009_preneoplasia | 1.46525005 |
| 69 | MP0002066_abnormal_motor_capabilities/c | 1.43724818 |
| 70 | MP0005083_abnormal_biliary_tract | 1.43721485 |
| 71 | MP0000778_abnormal_nervous_system | 1.43132927 |
| 72 | MP0003890_abnormal_embryonic-extraembry | 1.40048645 |
| 73 | MP0009785_altered_susceptibility_to | 1.39057893 |
| 74 | MP0005389_reproductive_system_phenotype | 1.37555002 |
| 75 | MP0000955_abnormal_spinal_cord | 1.37390777 |
| 76 | MP0001485_abnormal_pinna_reflex | 1.32878082 |
| 77 | MP0000681_abnormal_thyroid_gland | 1.31581925 |
| 78 | MP0001502_abnormal_circadian_rhythm | 1.28956501 |
| 79 | MP0005409_darkened_coat_color | 1.27484543 |
| 80 | MP0002837_dystrophic_cardiac_calcinosis | 1.26278039 |
| 81 | MP0002177_abnormal_outer_ear | 1.25153823 |
| 82 | MP0002882_abnormal_neuron_morphology | 1.24846553 |
| 83 | MP0005377_hearing/vestibular/ear_phenot | 1.23352455 |
| 84 | MP0003878_abnormal_ear_physiology | 1.23352455 |
| 85 | MP0005535_abnormal_body_temperature | 1.22488216 |
| 86 | MP0000534_abnormal_ureter_morphology | 1.17767849 |
| 87 | MP0000049_abnormal_middle_ear | 1.14547364 |
| 88 | MP0004742_abnormal_vestibular_system | 1.14300312 |
| 89 | MP0000751_myopathy | 1.12891319 |
| 90 | MP0005503_abnormal_tendon_morphology | 1.10445321 |
| 91 | MP0009379_abnormal_foot_pigmentation | 1.07593850 |
| 92 | MP0005636_abnormal_mineral_homeostasis | 1.06878478 |
| 93 | MP0003787_abnormal_imprinting | 1.06853409 |
| 94 | MP0002139_abnormal_hepatobiliary_system | 1.06807164 |
| 95 | MP0003879_abnormal_hair_cell | 1.06221961 |
| 96 | MP0009780_abnormal_chondrocyte_physiolo | 1.04729864 |
| 97 | MP0001664_abnormal_digestion | 1.04720740 |
| 98 | MP0003631_nervous_system_phenotype | 1.03220148 |
| 99 | MP0000013_abnormal_adipose_tissue | 1.03156458 |
| 100 | MP0003633_abnormal_nervous_system | 1.02360170 |
| 101 | MP0004043_abnormal_pH_regulation | 1.00652546 |
| 102 | MP0002152_abnormal_brain_morphology | 0.96590754 |
| 103 | MP0005025_abnormal_response_to | 0.96445374 |
| 104 | MP0003632_abnormal_nervous_system | 0.96329162 |
| 105 | MP0000631_abnormal_neuroendocrine_gland | 0.95121357 |
| 106 | MP0005499_abnormal_olfactory_system | 0.95052304 |
| 107 | MP0005394_taste/olfaction_phenotype | 0.95052304 |
| 108 | MP0002229_neurodegeneration | 0.94822894 |
| 109 | MP0002090_abnormal_vision | 0.94543699 |
| 110 | MP0004858_abnormal_nervous_system | 0.94530798 |
| 111 | MP0003942_abnormal_urinary_system | 0.94307703 |
| 112 | MP0000569_abnormal_digit_pigmentation | 0.91412729 |
| 113 | MP0004947_skin_inflammation | 0.91126345 |
| 114 | MP0001177_atelectasis | 0.90525436 |
| 115 | MP0004145_abnormal_muscle_electrophysio | 0.90309371 |
| 116 | MP0001873_stomach_inflammation | 0.89895316 |
| 117 | MP0002332_abnormal_exercise_endurance | 0.88046111 |
| 118 | MP0003121_genomic_imprinting | 0.87945982 |
| 119 | MP0002069_abnormal_eating/drinking_beha | 0.86598968 |
| 120 | MP0008874_decreased_physiological_sensi | 0.86390908 |
| 121 | MP0010386_abnormal_urinary_bladder | 0.86338630 |
| 122 | MP0000026_abnormal_inner_ear | 0.84410384 |
| 123 | MP0004885_abnormal_endolymph | 0.83812313 |
| 124 | MP0003690_abnormal_glial_cell | 0.83608330 |
| 125 | MP0005551_abnormal_eye_electrophysiolog | 0.82931349 |
| 126 | MP0003866_abnormal_defecation | 0.82442219 |
| 127 | MP0005334_abnormal_fat_pad | 0.81851064 |
| 128 | MP0000639_abnormal_adrenal_gland | 0.79760517 |
| 129 | MP0004085_abnormal_heartbeat | 0.77820729 |
| 130 | MP0005084_abnormal_gallbladder_morpholo | 0.77571638 |
| 131 | MP0003634_abnormal_glial_cell | 0.72929827 |
| 132 | MP0003959_abnormal_lean_body | 0.71770580 |
| 133 | MP0002419_abnormal_innate_immunity | 0.71721515 |
| 134 | MP0001963_abnormal_hearing_physiology | 0.71211785 |
| 135 | MP0000747_muscle_weakness | 0.68917031 |
| 136 | MP0008873_increased_physiological_sensi | 0.67838990 |
| 137 | MP0000470_abnormal_stomach_morphology | 0.67673190 |
| 138 | MP0003937_abnormal_limbs/digits/tail_de | 0.67193450 |
| 139 | MP0004215_abnormal_myocardial_fiber | 0.66513508 |
| 140 | MP0002752_abnormal_somatic_nervous | 0.66504864 |
| 141 | MP0000920_abnormal_myelination | 0.66384892 |
| 142 | MP0004130_abnormal_muscle_cell | 0.66292416 |
| 143 | MP0002876_abnormal_thyroid_physiology | 0.65834003 |
| 144 | MP0010307_abnormal_tumor_latency | 0.65655823 |
| 145 | MP0005257_abnormal_intraocular_pressure | 0.65643294 |
| 146 | MP0001286_abnormal_eye_development | 0.64405726 |
| 147 | MP0001943_abnormal_respiration | 0.64364323 |
| 148 | MP0004484_altered_response_of | 0.63457839 |
| 149 | MP0008961_abnormal_basal_metabolism | 0.63089564 |
| 150 | MP0002108_abnormal_muscle_morphology | 0.62951525 |
| 151 | MP0002638_abnormal_pupillary_reflex | 0.62653126 |
| 152 | MP0003724_increased_susceptibility_to | 0.62120521 |
| 153 | MP0000604_amyloidosis | 0.61469925 |
| 154 | MP0005310_abnormal_salivary_gland | 0.61304826 |
| 155 | MP0002136_abnormal_kidney_physiology | 0.61167007 |
| 156 | MP0001299_abnormal_eye_distance/ | 0.60467318 |
| 157 | MP0003137_abnormal_impulse_conducting | 0.60372126 |
| 158 | MP0002928_abnormal_bile_duct | 0.60058213 |
| 159 | MP0001765_abnormal_ion_homeostasis | 0.59795445 |
| 160 | MP0005248_abnormal_Harderian_gland | 0.59069044 |
| 161 | MP0002092_abnormal_eye_morphology | 0.58937178 |
| 162 | MP0006035_abnormal_mitochondrial_morpho | 0.58470312 |
| 163 | MP0000538_abnormal_urinary_bladder | 0.57680770 |
| 164 | MP0006072_abnormal_retinal_apoptosis | 0.57202904 |
| 165 | MP0003123_paternal_imprinting | 0.56797514 |
| 166 | MP0005379_endocrine/exocrine_gland_phen | 0.55199682 |
| 167 | MP0000465_gastrointestinal_hemorrhage | 0.54478241 |
| 168 | MP0001756_abnormal_urination | 0.53473287 |
| 169 | MP0005623_abnormal_meninges_morphology | 0.53360737 |
| 170 | MP0001919_abnormal_reproductive_system | 0.52591861 |
| 171 | MP0001270_distended_abdomen | 0.51582191 |
| 172 | MP0002148_abnormal_hypersensitivity_rea | 0.51079893 |
| 173 | MP0004233_abnormal_muscle_weight | 0.50887601 |
| 174 | MP0002697_abnormal_eye_size | 0.50877812 |
| 175 | MP0000579_abnormal_nail_morphology | 0.48426218 |
| 176 | MP0000537_abnormal_urethra_morphology | 0.48160297 |
| 177 | MP0000371_diluted_coat_color | 0.47917140 |
| 178 | MP0001790_abnormal_immune_system | 0.47811177 |
| 179 | MP0005387_immune_system_phenotype | 0.47811177 |
| 180 | MP0003828_pulmonary_edema | 0.46887642 |
| 181 | MP0008877_abnormal_DNA_methylation | 0.46637848 |
| 182 | MP0004197_abnormal_fetal_growth/weight/ | 0.46467076 |
| 183 | MP0004264_abnormal_extraembryonic_tissu | 0.46000370 |
| 184 | MP0008875_abnormal_xenobiotic_pharmacok | 0.45324311 |
| 185 | MP0002116_abnormal_craniofacial_bone | 0.45317645 |
| 186 | MP0003953_abnormal_hormone_level | 0.45270993 |
| 187 | MP0001663_abnormal_digestive_system | 0.43797070 |
| 188 | MP0004133_heterotaxia | 0.41124058 |
| 189 | MP0008469_abnormal_protein_level | 0.39102546 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Limb dystonia (HP:0002451) | 9.12109026 |
| 2 | Tetany (HP:0001281) | 8.21146359 |
| 3 | Hypomagnesemia (HP:0002917) | 7.52230556 |
| 4 | Focal motor seizures (HP:0011153) | 7.03892414 |
| 5 | Thyroid-stimulating hormone excess (HP:0002925) | 6.71141306 |
| 6 | Abnormality of magnesium homeostasis (HP:0004921) | 6.43008559 |
| 7 | Visual hallucinations (HP:0002367) | 6.13433596 |
| 8 | Bell-shaped thorax (HP:0001591) | 5.86051876 |
| 9 | Myokymia (HP:0002411) | 5.77885681 |
| 10 | Polydipsia (HP:0001959) | 5.70555160 |
| 11 | Abnormal drinking behavior (HP:0030082) | 5.70555160 |
| 12 | Focal seizures (HP:0007359) | 5.39072565 |
| 13 | Increased purine levels (HP:0004368) | 5.07213845 |
| 14 | Hyperuricemia (HP:0002149) | 5.07213845 |
| 15 | Morphological abnormality of the middle ear (HP:0008609) | 4.65787281 |
| 16 | Pheochromocytoma (HP:0002666) | 4.63621217 |
| 17 | Progressive cerebellar ataxia (HP:0002073) | 4.45675694 |
| 18 | Atonic seizures (HP:0010819) | 4.42078817 |
| 19 | Failure to thrive in infancy (HP:0001531) | 4.41677872 |
| 20 | Hyperacusis (HP:0010780) | 4.36958527 |
| 21 | Stomatitis (HP:0010280) | 4.30473835 |
| 22 | Neuroendocrine neoplasm (HP:0100634) | 4.16242537 |
| 23 | Absence seizures (HP:0002121) | 4.14954640 |
| 24 | Renal tubular acidosis (HP:0001947) | 3.97542783 |
| 25 | Nephrocalcinosis (HP:0000121) | 3.97009792 |
| 26 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 3.93130913 |
| 27 | Generalized tonic-clonic seizures (HP:0002069) | 3.90451792 |
| 28 | Epileptic encephalopathy (HP:0200134) | 3.86657096 |
| 29 | Febrile seizures (HP:0002373) | 3.85030275 |
| 30 | Dialeptic seizures (HP:0011146) | 3.77644219 |
| 31 | Fibular aplasia (HP:0002990) | 3.73210418 |
| 32 | Hypercalciuria (HP:0002150) | 3.66281144 |
| 33 | Progressive inability to walk (HP:0002505) | 3.64211479 |
| 34 | Broad face (HP:0000283) | 3.55735507 |
| 35 | Polyuria (HP:0000103) | 3.55384564 |
| 36 | Vascular calcification (HP:0004934) | 3.54018102 |
| 37 | Facial cleft (HP:0002006) | 3.32833806 |
| 38 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.30559219 |
| 39 | Abnormality of purine metabolism (HP:0004352) | 3.22675474 |
| 40 | Synostosis involving the elbow (HP:0003938) | 3.21847108 |
| 41 | Humeroradial synostosis (HP:0003041) | 3.21847108 |
| 42 | Action tremor (HP:0002345) | 3.14908971 |
| 43 | Abnormal eating behavior (HP:0100738) | 3.14030693 |
| 44 | Cerebral inclusion bodies (HP:0100314) | 3.10331058 |
| 45 | Polyphagia (HP:0002591) | 3.08343012 |
| 46 | Supranuclear gaze palsy (HP:0000605) | 3.05656535 |
| 47 | Anxiety (HP:0000739) | 3.05560961 |
| 48 | Abnormality of the pubic bones (HP:0003172) | 3.03612351 |
| 49 | Stomach cancer (HP:0012126) | 3.00860859 |
| 50 | Truncal ataxia (HP:0002078) | 3.00734112 |
| 51 | Abnormality of the columella (HP:0009929) | 3.00055603 |
| 52 | Cardiovascular calcification (HP:0011915) | 2.98501545 |
| 53 | Hypoplastic ischia (HP:0003175) | 2.95830713 |
| 54 | Chronic bronchitis (HP:0004469) | 2.94497160 |
| 55 | Depression (HP:0000716) | 2.92643776 |
| 56 | Broad-based gait (HP:0002136) | 2.91015597 |
| 57 | Hypoventilation (HP:0002791) | 2.89430755 |
| 58 | Hypothermia (HP:0002045) | 2.81503525 |
| 59 | Abnormal urine output (HP:0012590) | 2.77615925 |
| 60 | Hoarse voice (HP:0001609) | 2.77597968 |
| 61 | Bradykinesia (HP:0002067) | 2.77576133 |
| 62 | Ankle clonus (HP:0011448) | 2.77048949 |
| 63 | Mutism (HP:0002300) | 2.74118815 |
| 64 | Patent foramen ovale (HP:0001655) | 2.73873265 |
| 65 | Cerebral hemorrhage (HP:0001342) | 2.66369334 |
| 66 | Acute necrotizing encephalopathy (HP:0006965) | 2.66207434 |
| 67 | Gaze-evoked nystagmus (HP:0000640) | 2.65678669 |
| 68 | Microglossia (HP:0000171) | 2.64968188 |
| 69 | Abnormal pupillary function (HP:0007686) | 2.60164577 |
| 70 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.59483692 |
| 71 | Eczematoid dermatitis (HP:0000976) | 2.57318491 |
| 72 | Rigidity (HP:0002063) | 2.56819068 |
| 73 | Delayed gross motor development (HP:0002194) | 2.56420781 |
| 74 | Abnormality of renal excretion (HP:0011036) | 2.53292640 |
| 75 | Hypokinesia (HP:0002375) | 2.52787507 |
| 76 | Hyperventilation (HP:0002883) | 2.52413636 |
| 77 | Dysdiadochokinesis (HP:0002075) | 2.51591255 |
| 78 | Poor eye contact (HP:0000817) | 2.51197217 |
| 79 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.51131049 |
| 80 | Dysmetria (HP:0001310) | 2.50967587 |
| 81 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.50764510 |
| 82 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.50669856 |
| 83 | Progressive macrocephaly (HP:0004481) | 2.50206835 |
| 84 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.47013278 |
| 85 | Impaired social interactions (HP:0000735) | 2.46306487 |
| 86 | Abnormal social behavior (HP:0012433) | 2.46306487 |
| 87 | Abnormality of the ischium (HP:0003174) | 2.44924802 |
| 88 | Hyperthyroidism (HP:0000836) | 2.41715501 |
| 89 | Abnormality of homocysteine metabolism (HP:0010919) | 2.40319485 |
| 90 | Homocystinuria (HP:0002156) | 2.40319485 |
| 91 | Mesomelia (HP:0003027) | 2.39253396 |
| 92 | Abnormal number of erythroid precursors (HP:0012131) | 2.38590501 |
| 93 | Muscular hypotonia of the trunk (HP:0008936) | 2.35786819 |
| 94 | Papilledema (HP:0001085) | 2.35374766 |
| 95 | Median cleft lip (HP:0000161) | 2.32337739 |
| 96 | Potter facies (HP:0002009) | 2.30653431 |
| 97 | Facial shape deformation (HP:0011334) | 2.30653431 |
| 98 | Esophageal atresia (HP:0002032) | 2.29574876 |
| 99 | Drooling (HP:0002307) | 2.29546783 |
| 100 | Excessive salivation (HP:0003781) | 2.29546783 |
| 101 | Amblyopia (HP:0000646) | 2.28603813 |
| 102 | Scanning speech (HP:0002168) | 2.28489570 |
| 103 | Torticollis (HP:0000473) | 2.27541879 |
| 104 | Neurofibrillary tangles (HP:0002185) | 2.26606952 |
| 105 | Postural instability (HP:0002172) | 2.26533173 |
| 106 | Mitochondrial inheritance (HP:0001427) | 2.26370685 |
| 107 | Urinary urgency (HP:0000012) | 2.24620372 |
| 108 | Spinal muscular atrophy (HP:0007269) | 2.24024318 |
| 109 | Abnormality of binocular vision (HP:0011514) | 2.22793921 |
| 110 | Diplopia (HP:0000651) | 2.22793921 |
| 111 | Focal dystonia (HP:0004373) | 2.22784957 |
| 112 | Inability to walk (HP:0002540) | 2.22232721 |
| 113 | Postural tremor (HP:0002174) | 2.20537322 |
| 114 | Esotropia (HP:0000565) | 2.20165045 |
| 115 | Renal tubular dysfunction (HP:0000124) | 2.19837497 |
| 116 | Split foot (HP:0001839) | 2.19373359 |
| 117 | Hemiparesis (HP:0001269) | 2.19309912 |
| 118 | Abnormality of nucleobase metabolism (HP:0010932) | 2.18002439 |
| 119 | Delusions (HP:0000746) | 2.17582716 |
| 120 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.15719820 |
| 121 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.15719820 |
| 122 | Epileptiform EEG discharges (HP:0011182) | 2.15588413 |
| 123 | Spastic gait (HP:0002064) | 2.15564531 |
| 124 | Abnormal finger flexion creases (HP:0006143) | 2.15495874 |
| 125 | Agitation (HP:0000713) | 2.15198593 |
| 126 | Long clavicles (HP:0000890) | 2.15034471 |
| 127 | EEG with generalized epileptiform discharges (HP:0011198) | 2.14329350 |
| 128 | Gait ataxia (HP:0002066) | 2.12101271 |
| 129 | Diminished movement (HP:0002374) | 2.11705300 |
| 130 | Hypoplastic iliac wings (HP:0002866) | 2.11612591 |
| 131 | Dyskinesia (HP:0100660) | 2.10213366 |
| 132 | Abnormality of the corticospinal tract (HP:0002492) | 2.09130513 |
| 133 | Abnormality of chromosome segregation (HP:0002916) | 2.08837881 |
| 134 | Abnormality of the labia minora (HP:0012880) | 2.08270551 |
| 135 | Fetal akinesia sequence (HP:0001989) | 2.07537896 |
| 136 | Hypercortisolism (HP:0001578) | 2.07263118 |
| 137 | Goiter (HP:0000853) | 2.07089995 |
| 138 | 2-3 toe syndactyly (HP:0004691) | 2.05273576 |
| 139 | Craniofacial dystonia (HP:0012179) | 2.02969434 |
| 140 | Resting tremor (HP:0002322) | 2.02713983 |
| 141 | Genital tract atresia (HP:0001827) | 2.02687514 |
| 142 | Vaginal atresia (HP:0000148) | 2.02553289 |
| 143 | Hemiplegia (HP:0002301) | 2.01776334 |
| 144 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.01370520 |
| 145 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.01271323 |
| 146 | Psychosis (HP:0000709) | 2.01141664 |
| 147 | Generalized myoclonic seizures (HP:0002123) | 2.00746675 |
| 148 | Gait imbalance (HP:0002141) | 1.99151909 |
| 149 | Insidious onset (HP:0003587) | 1.99131084 |
| 150 | Termporal pattern (HP:0011008) | 1.99131084 |
| 151 | Acute encephalopathy (HP:0006846) | 1.98183515 |
| 152 | Renovascular hypertension (HP:0100817) | 1.98079344 |
| 153 | Status epilepticus (HP:0002133) | 1.97836212 |
| 154 | Hypsarrhythmia (HP:0002521) | 1.97458950 |
| 155 | Poor suck (HP:0002033) | 1.97357626 |
| 156 | Ventricular fibrillation (HP:0001663) | 1.96218452 |
| 157 | Episodic fever (HP:0001954) | 1.94908488 |
| 158 | Bicornuate uterus (HP:0000813) | 1.92410388 |
| 159 | Overriding aorta (HP:0002623) | 1.90055104 |
| 160 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.89117794 |
| 161 | Neuronal loss in central nervous system (HP:0002529) | 1.87899435 |
| 162 | Abnormality of the parathyroid morphology (HP:0011766) | 1.87117590 |
| 163 | Lymphangioma (HP:0100764) | 1.85858034 |
| 164 | Abnormality of the parietal bone (HP:0002696) | 1.82958071 |
| 165 | Tented upper lip vermilion (HP:0010804) | 1.81882727 |
| 166 | Abnormality of macrophages (HP:0004311) | 1.78193876 |
| 167 | Abnormality of the nasal septum (HP:0000419) | 1.77299172 |
| 168 | Poor coordination (HP:0002370) | 1.76185140 |
| 169 | Bicuspid aortic valve (HP:0001647) | 1.75960997 |
| 170 | Absent thumb (HP:0009777) | 1.74784480 |
| 171 | Abnormality of the fingertips (HP:0001211) | 1.74452477 |
| 172 | Self-mutilation (HP:0000742) | 1.73074336 |
| 173 | Abnormality of the lacrimal duct (HP:0011481) | 1.71299138 |
| 174 | Cleft eyelid (HP:0000625) | 1.70726229 |
| 175 | Methylmalonic acidemia (HP:0002912) | 1.70334545 |
| 176 | Coarctation of aorta (HP:0001680) | 1.69905972 |
| 177 | Astigmatism (HP:0000483) | 1.68706979 |
| 178 | Nasolacrimal duct obstruction (HP:0000579) | 1.65496675 |
| 179 | Chronic otitis media (HP:0000389) | 1.65144414 |
| 180 | Absent phalangeal crease (HP:0006109) | 1.62828975 |
| 181 | Generalized hypotonia (HP:0001290) | 1.61557737 |
| 182 | Abnormal biliary tract physiology (HP:0012439) | 1.60910052 |
| 183 | Bile duct proliferation (HP:0001408) | 1.60910052 |
| 184 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.59225190 |
| 185 | Congenital stationary night blindness (HP:0007642) | 1.59175429 |
| 186 | Cutaneous finger syndactyly (HP:0010554) | 1.54598977 |
| 187 | Cupped ear (HP:0000378) | 1.54277013 |
| 188 | Abnormality of the carotid arteries (HP:0005344) | 1.53850076 |
| 189 | Abnormality of the dental root (HP:0006486) | 1.53585036 |
| 190 | Taurodontia (HP:0000679) | 1.53585036 |
| 191 | Abnormality of permanent molar morphology (HP:0011071) | 1.53585036 |
| 192 | Reticulocytopenia (HP:0001896) | 1.53478329 |
| 193 | Recurrent urinary tract infections (HP:0000010) | 1.53317751 |
| 194 | Wrist flexion contracture (HP:0001239) | 1.51781745 |
| 195 | Spontaneous hematomas (HP:0007420) | 1.50327381 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K12 | 4.13232171 |
| 2 | PIK3CA | 3.73920251 |
| 3 | NTRK3 | 3.72277055 |
| 4 | CDK12 | 3.68953027 |
| 5 | TRIB3 | 3.51346490 |
| 6 | MAP3K4 | 3.48293499 |
| 7 | MAP3K9 | 3.44352290 |
| 8 | PDK2 | 3.42690207 |
| 9 | TAOK3 | 3.16354793 |
| 10 | MAPKAPK5 | 3.06347633 |
| 11 | MAP2K7 | 2.98438456 |
| 12 | PNCK | 2.96351591 |
| 13 | EPHB1 | 2.87334190 |
| 14 | MAPK15 | 2.86758419 |
| 15 | MAP2K4 | 2.76831249 |
| 16 | EPHA4 | 2.60484701 |
| 17 | MINK1 | 2.60284543 |
| 18 | ABL2 | 2.57634511 |
| 19 | MAP2K3 | 2.53305414 |
| 20 | MAP3K6 | 2.48779010 |
| 21 | MARK1 | 2.42703422 |
| 22 | NEK2 | 2.42503335 |
| 23 | GRK5 | 2.42240372 |
| 24 | NTRK2 | 2.01381731 |
| 25 | PLK2 | 1.95047221 |
| 26 | ARAF | 1.88344623 |
| 27 | IKBKE | 1.88181038 |
| 28 | CASK | 1.84827761 |
| 29 | BCKDK | 1.79718839 |
| 30 | TLK1 | 1.73625038 |
| 31 | NTRK1 | 1.69356146 |
| 32 | DMPK | 1.66760117 |
| 33 | PDPK1 | 1.60577148 |
| 34 | NLK | 1.59638354 |
| 35 | EPHA3 | 1.59312431 |
| 36 | RPS6KA6 | 1.56588369 |
| 37 | PAK6 | 1.55086890 |
| 38 | KSR2 | 1.54723837 |
| 39 | CSNK1G2 | 1.51737172 |
| 40 | EPHA2 | 1.49897874 |
| 41 | PKN2 | 1.49866838 |
| 42 | MAP2K2 | 1.48806276 |
| 43 | CDK5 | 1.46862457 |
| 44 | CAMK2A | 1.36090469 |
| 45 | CSNK1G3 | 1.35614777 |
| 46 | MAP3K14 | 1.33871298 |
| 47 | RPS6KL1 | 1.33482297 |
| 48 | RPS6KC1 | 1.33482297 |
| 49 | CHUK | 1.33335487 |
| 50 | FES | 1.32671068 |
| 51 | PDK1 | 1.32187083 |
| 52 | FGFR2 | 1.28406061 |
| 53 | TRIM28 | 1.26434109 |
| 54 | ADRBK2 | 1.25366050 |
| 55 | CAMK2B | 1.24824934 |
| 56 | CDK19 | 1.22879889 |
| 57 | CDK18 | 1.22628184 |
| 58 | CDK15 | 1.20629842 |
| 59 | CDK7 | 1.20549218 |
| 60 | RPS6KB2 | 1.20525368 |
| 61 | UHMK1 | 1.20370584 |
| 62 | IRAK4 | 1.18352816 |
| 63 | FGR | 1.18086302 |
| 64 | KSR1 | 1.16580841 |
| 65 | GRK6 | 1.15762697 |
| 66 | MAPK13 | 1.15564449 |
| 67 | CDK14 | 1.15125909 |
| 68 | TAOK1 | 1.13381630 |
| 69 | MAP3K13 | 1.12839661 |
| 70 | IRAK1 | 1.11401999 |
| 71 | DAPK2 | 1.10391584 |
| 72 | PRKCG | 1.09631717 |
| 73 | LATS2 | 1.07812422 |
| 74 | RET | 1.07153094 |
| 75 | CDK11A | 1.07028971 |
| 76 | RIPK4 | 1.06625631 |
| 77 | STK39 | 1.03405133 |
| 78 | STK38 | 1.03318776 |
| 79 | TBK1 | 1.03055919 |
| 80 | CAMKK1 | 1.01754378 |
| 81 | CAMK2D | 1.01381473 |
| 82 | IKBKB | 0.96645851 |
| 83 | PTK2B | 0.96079417 |
| 84 | SIK2 | 0.95798691 |
| 85 | OXSR1 | 0.94986195 |
| 86 | MAP2K6 | 0.94437738 |
| 87 | TNIK | 0.93977434 |
| 88 | MAPK12 | 0.93660885 |
| 89 | NEK6 | 0.92058834 |
| 90 | PHKG1 | 0.90378887 |
| 91 | PHKG2 | 0.90378887 |
| 92 | MAP3K5 | 0.89633229 |
| 93 | CAMK2G | 0.89313840 |
| 94 | DAPK1 | 0.87244846 |
| 95 | TNK2 | 0.86635593 |
| 96 | PRKACB | 0.86560092 |
| 97 | CSNK1G1 | 0.86052051 |
| 98 | PTK6 | 0.86022164 |
| 99 | MAP3K3 | 0.86010615 |
| 100 | WNK4 | 0.85242597 |
| 101 | CSF1R | 0.84341584 |
| 102 | NME1 | 0.83303779 |
| 103 | DYRK1A | 0.80049764 |
| 104 | PRKCI | 0.78733865 |
| 105 | TYRO3 | 0.78561178 |
| 106 | WNK1 | 0.77981179 |
| 107 | PRKD3 | 0.75648496 |
| 108 | NUAK1 | 0.74897925 |
| 109 | STK38L | 0.74311124 |
| 110 | MAP3K10 | 0.73916103 |
| 111 | WNK3 | 0.73650616 |
| 112 | PAK3 | 0.73518443 |
| 113 | SMG1 | 0.72993572 |
| 114 | BTK | 0.72635101 |
| 115 | CAMK1G | 0.72205515 |
| 116 | EIF2AK2 | 0.69430849 |
| 117 | SGK494 | 0.69279588 |
| 118 | SGK223 | 0.69279588 |
| 119 | CAMK1 | 0.68113393 |
| 120 | PLK4 | 0.64995961 |
| 121 | MAP3K1 | 0.64777760 |
| 122 | STK11 | 0.64757151 |
| 123 | PRKCH | 0.63552085 |
| 124 | FGFR4 | 0.63242890 |
| 125 | AKT2 | 0.61976742 |
| 126 | ERBB4 | 0.61851340 |
| 127 | GRK7 | 0.61654724 |
| 128 | ERBB2 | 0.60711378 |
| 129 | CAMKK2 | 0.60271996 |
| 130 | ADRBK1 | 0.58745995 |
| 131 | LATS1 | 0.55253790 |
| 132 | PINK1 | 0.54712032 |
| 133 | MKNK2 | 0.54521139 |
| 134 | SCYL2 | 0.53290246 |
| 135 | SGK2 | 0.52341849 |
| 136 | RPS6KA2 | 0.52304563 |
| 137 | FER | 0.50858329 |
| 138 | JAK2 | 0.50855401 |
| 139 | MAPKAPK2 | 0.50029751 |
| 140 | RAF1 | 0.49305330 |
| 141 | MAP3K2 | 0.49181972 |
| 142 | PRKD2 | 0.48844101 |
| 143 | SGK1 | 0.48843712 |
| 144 | VRK1 | 0.48271753 |
| 145 | CAMK4 | 0.48253437 |
| 146 | PRKCE | 0.47068272 |
| 147 | PLK3 | 0.46595491 |
| 148 | BCR | 0.46102116 |
| 149 | ALK | 0.45823368 |
| 150 | LMTK2 | 0.45647231 |
| 151 | TAOK2 | 0.44146173 |
| 152 | MAP3K7 | 0.44138078 |
| 153 | BMPR2 | 0.43688723 |
| 154 | FYN | 0.42873422 |
| 155 | RPS6KA3 | 0.42485486 |
| 156 | ROCK2 | 0.41605616 |
| 157 | TYK2 | 0.40926063 |
| 158 | PRKDC | 0.40761929 |
| 159 | MAP3K11 | 0.40042770 |
| 160 | PRKACA | 0.39052037 |
| 161 | CDC42BPA | 0.38872631 |
| 162 | CSNK1A1 | 0.38727889 |
| 163 | BRAF | 0.37048524 |
| 164 | PKN1 | 0.36881019 |
| 165 | MOS | 0.36426305 |
| 166 | PIK3CG | 0.35524909 |
| 167 | MAPK10 | 0.35379249 |
| 168 | PRKCZ | 0.35161469 |
| 169 | GSK3A | 0.35089859 |
| 170 | TSSK6 | 0.34902071 |
| 171 | SIK3 | 0.34397680 |
| 172 | CSNK1E | 0.33637278 |
| 173 | PIM1 | 0.31436140 |
| 174 | JAK1 | 0.29446000 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.16863634 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.98597804 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 3.78061036 |
| 4 | One carbon pool by folate_Homo sapiens_hsa00670 | 3.25148076 |
| 5 | Cocaine addiction_Homo sapiens_hsa05030 | 2.95502522 |
| 6 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.90749837 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.79497163 |
| 8 | Tight junction_Homo sapiens_hsa04530 | 2.70784927 |
| 9 | Thyroid cancer_Homo sapiens_hsa05216 | 2.67052424 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.58100887 |
| 11 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 2.56527187 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.53042081 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.51071845 |
| 14 | Parkinsons disease_Homo sapiens_hsa05012 | 2.48529998 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.46556421 |
| 16 | Hepatitis C_Homo sapiens_hsa05160 | 2.45437653 |
| 17 | Morphine addiction_Homo sapiens_hsa05032 | 2.28127792 |
| 18 | Olfactory transduction_Homo sapiens_hsa04740 | 2.25352123 |
| 19 | Circadian entrainment_Homo sapiens_hsa04713 | 2.21244917 |
| 20 | Long-term potentiation_Homo sapiens_hsa04720 | 2.19675516 |
| 21 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.16801163 |
| 22 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.15220313 |
| 23 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.10874848 |
| 24 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.04034094 |
| 25 | Salivary secretion_Homo sapiens_hsa04970 | 1.89444763 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83938289 |
| 27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.81700590 |
| 28 | Insulin secretion_Homo sapiens_hsa04911 | 1.78343764 |
| 29 | Long-term depression_Homo sapiens_hsa04730 | 1.76407319 |
| 30 | Alzheimers disease_Homo sapiens_hsa05010 | 1.75610628 |
| 31 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.72345609 |
| 32 | Taste transduction_Homo sapiens_hsa04742 | 1.71757160 |
| 33 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.61623945 |
| 34 | Renin secretion_Homo sapiens_hsa04924 | 1.57653514 |
| 35 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.55814944 |
| 36 | Homologous recombination_Homo sapiens_hsa03440 | 1.55706419 |
| 37 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.53317437 |
| 38 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.51935804 |
| 39 | Ribosome_Homo sapiens_hsa03010 | 1.51588239 |
| 40 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.51061443 |
| 41 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.46825163 |
| 42 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.41026029 |
| 43 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.37927663 |
| 44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.37740975 |
| 45 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.37044743 |
| 46 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.33847807 |
| 47 | Huntingtons disease_Homo sapiens_hsa05016 | 1.33260861 |
| 48 | Gap junction_Homo sapiens_hsa04540 | 1.31311761 |
| 49 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.29784517 |
| 50 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.28422682 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.25648862 |
| 52 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.24699457 |
| 53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.22817628 |
| 54 | Galactose metabolism_Homo sapiens_hsa00052 | 1.19361840 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.19228584 |
| 56 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.18622520 |
| 57 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.17907029 |
| 58 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.17141888 |
| 59 | Prostate cancer_Homo sapiens_hsa05215 | 1.16639934 |
| 60 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.12766388 |
| 61 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.11910199 |
| 62 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.06521808 |
| 63 | Mineral absorption_Homo sapiens_hsa04978 | 1.04323934 |
| 64 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.04301243 |
| 65 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.02993745 |
| 66 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.01606728 |
| 67 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.99333717 |
| 68 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.98697641 |
| 69 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.98574790 |
| 70 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.97062997 |
| 71 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.92653533 |
| 72 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.91438545 |
| 73 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.89102500 |
| 74 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.89007193 |
| 75 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.86770693 |
| 76 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.85269863 |
| 77 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.84359744 |
| 78 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.83386609 |
| 79 | Alcoholism_Homo sapiens_hsa05034 | 0.83075232 |
| 80 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.81544706 |
| 81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.80945373 |
| 82 | Leishmaniasis_Homo sapiens_hsa05140 | 0.80336276 |
| 83 | Axon guidance_Homo sapiens_hsa04360 | 0.78206020 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.76673631 |
| 85 | Melanogenesis_Homo sapiens_hsa04916 | 0.75893500 |
| 86 | Shigellosis_Homo sapiens_hsa05131 | 0.75522706 |
| 87 | Hepatitis B_Homo sapiens_hsa05161 | 0.74740479 |
| 88 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.74697093 |
| 89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.74112811 |
| 90 | Purine metabolism_Homo sapiens_hsa00230 | 0.72574923 |
| 91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.72441182 |
| 92 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.71491874 |
| 93 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70767114 |
| 94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.70604849 |
| 95 | Histidine metabolism_Homo sapiens_hsa00340 | 0.70096666 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70027854 |
| 97 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68902382 |
| 98 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.68595997 |
| 99 | Tuberculosis_Homo sapiens_hsa05152 | 0.68398622 |
| 100 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67780637 |
| 101 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.67658365 |
| 102 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.67491641 |
| 103 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66164104 |
| 104 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.65902973 |
| 105 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.65577460 |
| 106 | Basal transcription factors_Homo sapiens_hsa03022 | 0.64895051 |
| 107 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.64212894 |
| 108 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.63017249 |
| 109 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.62412983 |
| 110 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.62392191 |
| 111 | Glioma_Homo sapiens_hsa05214 | 0.61936691 |
| 112 | Mismatch repair_Homo sapiens_hsa03430 | 0.59164241 |
| 113 | Measles_Homo sapiens_hsa05162 | 0.59027399 |
| 114 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.58645425 |
| 115 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.58339548 |
| 116 | Phototransduction_Homo sapiens_hsa04744 | 0.57941424 |
| 117 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.56655846 |
| 118 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54821286 |
| 119 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.54225578 |
| 120 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.53931637 |
| 121 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.52744746 |
| 122 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52653259 |
| 123 | Adherens junction_Homo sapiens_hsa04520 | 0.52610449 |
| 124 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51967431 |
| 125 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51465427 |
| 126 | ABC transporters_Homo sapiens_hsa02010 | 0.50967815 |
| 127 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.50753271 |
| 128 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49871549 |
| 129 | Influenza A_Homo sapiens_hsa05164 | 0.49311281 |
| 130 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49210783 |
| 131 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.48000884 |
| 132 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.47898840 |
| 133 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.47319324 |
| 134 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46870733 |
| 135 | Sulfur relay system_Homo sapiens_hsa04122 | 0.46226781 |
| 136 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45908308 |
| 137 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.45904663 |
| 138 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.45265438 |
| 139 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.41305947 |
| 140 | Salmonella infection_Homo sapiens_hsa05132 | 0.40611707 |
| 141 | RNA degradation_Homo sapiens_hsa03018 | 0.39875570 |
| 142 | Legionellosis_Homo sapiens_hsa05134 | 0.39304843 |
| 143 | RNA transport_Homo sapiens_hsa03013 | 0.38856971 |
| 144 | Prion diseases_Homo sapiens_hsa05020 | 0.38843678 |
| 145 | Apoptosis_Homo sapiens_hsa04210 | 0.38418627 |
| 146 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38113665 |
| 147 | Phagosome_Homo sapiens_hsa04145 | 0.37958536 |
| 148 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36886007 |
| 149 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34498717 |
| 150 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.33930972 |
| 151 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.33892001 |
| 152 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.33327129 |
| 153 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33145953 |
| 154 | Insulin resistance_Homo sapiens_hsa04931 | 0.32178120 |
| 155 | Bile secretion_Homo sapiens_hsa04976 | 0.31872969 |
| 156 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.31671566 |
| 157 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30856681 |
| 158 | Pathways in cancer_Homo sapiens_hsa05200 | 0.29639292 |
| 159 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29623989 |
| 160 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29127953 |
| 161 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.28564782 |
| 162 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.28390217 |
| 163 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.27610157 |
| 164 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.27256492 |
| 165 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.26067738 |
| 166 | Endocytosis_Homo sapiens_hsa04144 | 0.24965016 |
| 167 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.24560727 |
| 168 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22842941 |
| 169 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.21656190 |
| 170 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.21655639 |
| 171 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.21435085 |
| 172 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.20568906 |
| 173 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.18554918 |
| 174 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.17129076 |
| 175 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.16740178 |

